Position in GH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$258,801
New position
Shares Held
1,725
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#421
of 594 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026RITHOLTZ WEALTH MANAGEMENT holds $11,105,744 across 9 Diagnostics & Research names. GH ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
7,503 | $3,761,704 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
6,366 | $3,351,317 | |
| 3 | DHR |
Danaher Corp /De/
|
9,774 | $1,861,751 | |
| 4 | WAT |
Waters Corp /De/
|
1,261 | $472,925 | |
| 5 | NTRA |
Natera, Inc.
|
1,655 | $449,249 | |
| 6 | LH |
Labcorp Holdings Inc.
|
1,464 | $409,920 | |
| 7 | A |
Agilent Technologies, Inc.
|
2,128 | $282,662 | |
| 8 | GH |
Guardant Health, Inc.
This page
|
1,725 | $258,801 |
All Filings in GH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $258,801 | 1,725 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||